Browsing Tag
radiotherapeutics
2 posts
Why pediatric ependymoma inclusion may be the bigger strategic signal for Plus Therapeutics
Why pediatric ependymoma may be the bigger strategic signal for Plus Therapeutics and what it means for REYOBIQ’s 2026 growth roadmap. Read more.
Investors eye Plus Therapeutics after promising ReSPECT-LM results and FDA fast-track push for REYOBIQ in brain metastases
See how Plus Therapeutics’ REYOBIQ delivered >75 percent benefit and no toxicity in its ReSPECT-LM trial—discover what this means for CNS cancer treatment and investors.